Quantitative electrochemical detection of cathepsin B activity in breast cancer cell lysates using carbon nanofiber nanoelectrode arrays toward identification of cancer formation

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 7, 2015, Pages 1695-1704

  Swisher, Luxi Z ^a   Prior, Allan M ^a   Gunaratna, Medha J ^a   Shishido, Stephanie ^a   Madiyar, Foram ^a   Nguyen, Thu A ^a   Hua, Duy H ^a   Li, Jun ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Cancer formation; Electrochemical protease profiling; Nanoelectrode array; Proteolytic activity; Vertically aligned carbon nanofibers

Indexed keywords

CARBON NANOFIBERS; CHEMICAL DETECTION; CYTOLOGY; DISEASES; ENZYME ACTIVITY; NANOFIBERS; ORGANOMETALLICS;

CANCER FORMATION; ELECTROCHEMICAL PROTEASE PROFILING; NANOELECTRODE ARRAY; PROTEOLYTIC ACTIVITIES; VERTICALLY ALIGNED CARBON NANOFIBERS;

CELLS;

CARBON NANOFIBER; CATHEPSIN B; FERROCENE; PROTEINASE; TETRAPEPTIDE; CARBON; NANOFIBER;

ALTERNATING CURRENT; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CELL; BREAST METASTASIS; CANCER CELL; CANCER DIAGNOSIS; CELL LYSATE; CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; ELECTRODE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; NANOELECTRODE; POTENTIOMETRY; PROTEIN DEGRADATION; BREAST NEOPLASMS; CHEMISTRY; GENETICS; ISOLATION AND PURIFICATION; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CARBON; CATHEPSIN B; CELL LINE, TUMOR; FEMALE; HUMANS; NANOFIBERS; PROTEOLYSIS;

EID: 84942115586     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.04.014     Document Type: Article

References (34)

1. Cancer facts and figure 2014 2014, American Cancer Society, Atlanta.
2. Kotaska K., Dusek P., Prusa R., Vesely S., Babjuk M. Urine and serum cathepsin B concentrations in the transitional cell carcinoma of the bladder. J Clin Lab Anal 2012, 26:61-65.
3. Sahai E. Mechanisms of cancer cell invasion. Curr Opin Genet Dev 2005, 15:87-96.
4. Lee M., Fridman R., Mobashery S. Extracellular proteases as targets for treatment of cancer metastases. Chem Soc Rev 2004, 33:401-409.
5. Koblinski J., Ahram M., Sloane B. Unraveling the role of proteases in cancer. Clin Chim Acta 2000, 291:113-135.
6. Sukoh N., Abe S., Ogura S., Isobe H., Takekawa H., Inoue K., et al. Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer. Cancer 1994, 74:46-51.
7. Nouh M.A., Mohamed M.M., El-Shinawi M., Shaalan M.A., Cavallo-Medved D., Khaled H.M., et al. Cathepsin B: a potential prognostic marker for inflammatory breast cancer. J Transl Med 2011, 9:1-8.
8. Mort J.S. Chapter 406-Cathepsin B. Handbook of proteolytic enzymes 2013, vol. 2:1784-1791. Academic Press, San Diego. 3rd ed.
9. Barrett A.J., Kirschke H. Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol 1981, 80:535-561.
10. Elliott E., Sloane B.F. The cysteine protease cathepsin B in cancer. Perspect Drug Discov 1996, 6:12-32.
11. Chen Q., Fei J., Wu L., Jiang Z., Wu Y., Zheng Y., et al. Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients. Oncol Lett 2011, 2:693-699.
12. Buck M.R., Roth M.J., Zhuang Z., Campo E., Rozhin J., Sloane B.F., et al. Increased levels of 72 kilodalton type IV collagenase and cathepsin B in microdissected human breast and colon carcinomas. Proc Am Assoc Cancer Res 1994, 35:59.
13. Emmert-Buck M.R., Roth M.J., Zhuang Z., Campo E., Rozhin J., Sloane B.F., et al. Increased gelatinanse A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 1994, 145:1285-1290.
14. Swisher L.Z., Syed L.U., Prior A.M., Madiyar F.R., Carlson K.R., Nguyen T.A., et al. Electrochemical protease biosensor based on enhanced AC voltammetry using carbon nanofiber nanoelectrode arrays. J Phys Chem C 2013, 117:4268-4277.
15. Swisher L.Z., Prior A.M., Shishido S., Nguyen T.A., Hua D.H., Li J. Quantitative electrochemical detection of cathepsin B activity in complex tissue lysates using enhanced AC voltammetry at carbon nanofiber nanoelectrode arrays. Biosens Bioelectron 2014, 56:129-136.
16. Syed L.U., Liu J., Prior A.M., Hua D.H., Li J. Enhanced electron transfer rates by AC voltammetry for ferrocenes attached to the end of embedded carbon nanofiber nanoelectrode array. Electroanalysis 2011, 23:1709-1717.
17. Mandadapu S.R.G.M., Tiew K.-C., Uy R.A.Z., Prior A.M., Alliston K.R., Hua D.H., et al. Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors. Bioorg Med Chem Lett 2013, 23:62-65.
18. Li J., Ng H.T., Cassell A., Fan W., Chen H., Ye Q., et al. Carbon nanotube nanoelectrode array for ultrasensitive DNA detection. Nano Lett 2003, 3:597-602.
19. Li J., Koehne J.E., Cassell A.M., Chen H., Ng H.T., Ye Q., et al. Inlaid multi-walled carbon nanotube nanoelectrode arrays for electroanalysis. Electroanalysis 2005, 17:15-27.
20. Siddiqui S., Arumugam P.U., Chen H., Li J., Meyyappan M. Characterization of carbon nanofiber electrode arrays using electrochemical impedance spectroscopy: effect of scaling down electrode size. ACS Nano 2010, 4:955-961.
21. Arumugam P.U., Chen H., Siddiqui S., Weinrich J.A.P., Jejelowo A., Li J., et al. Wafer-scale fabrication of patterned carbon nanofiber nanoelectrode arrays: a route for development of multiplexed, ultrasensitive disposable biosensors. Biosens Bioelectron 2009, 24:2818-2824.
22. Creager S., Yu C.J., Bamdad C., O'Connor S., MacLean T., Lam E., et al. Electron transfer at electrodes through conjugated "molecular wire" bridges. J Am Chem Soc 1999, 121:1059-1064.
23. Gutiérrez O.A., Chavez M., Lissi E. A theoretical approach to some analytical properties of heterogeneous enzymatic assays. Anal Chem 2004, 76:2664-2668.
24. Muss H.B. Endocrine therapy for advanced breast cancer: a review. Breast Cancer Res Treat 1992, 21:15-26.
25. Santen R.J., Manni A., Harvey H., Redmond C. Endocrine treatment of breast cancer in women. Endocr Rev 1990, 11:221-265.
26. Lerner L.J., Jordan V.C. Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture. Cancer Res 1990, 50:4177-4189.
27. Jordan V.C. Alternate antiestrogens and approaches to the prevention of breast cancer. J Cell Biochem Suppl 1995, 22:51-57.
28. Morrow M., Jordan V.C. Molecular mechanisms of resistance to tamoxifen therapy in breast cancer. Arch Surg 1993, 128:1187-1191.
29. Clark G.M., Hilsenbeck S.G., Ravdin P.M., De Laurentiis M., Osborne C.K. Prognostic factors: rationale and methods of analysis and integration. Breast Cancer Res Treat 1994, 32:105-112.
30. Ethier S.P. Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst 1995, 87:964-973.
31. Dickson R.B., Lippman M.E. Growth factors in breast cancer. Endocr Rev 1995, 16:559-589.
32. King M.C. Breast cancer genes: how many, where and who are they?. Nat Genet 1992, 2:89-90.
33. Nägler D.K., Storer A.C., Portaro F.C.V., Carmona E., Juliano L., Ménard R. Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. Biochemical 1997, 36:12608-12615.
34. Cotrin S.S., Puzer L., de Souza Judice W.A., Juliano L., Carmona A.K., Juliano M.A. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides to define substrate specificity of carboxydipeptidases: assays with human cathepsin B. Anal Biochem 2004, 335:244-252.